Anavex Life Sciences Announces Oral Blarcamesine Cognitive Resilience Results Approximating Normal Aging in New Precision Medicine Clinical Data from Phase IIb/III Alzheimer's Disease Trial Biotech Investing
Aclaris Therapeutics Announces Late-Breaking Abstract and Oral Presentation On ATI-2138 Phase 2a Results at the 2025 European Academy of Dermatology and Venereology Congress Biotech Investing
Immunic Receives Notice of Allowance for United States Patent Protecting Vidofludimus Calcium's Dose Strengths in Progressive Multiple Sclerosis Biotech Investing
AMGEN AND KYOWA KIRIN ANNOUNCE TOP-LINE RESULTS FROM ROCATINLIMAB PHASE 3 ASCEND LONG-TERM EXTENSION STUDY IN ADULTS WITH MODERATE TO SEVERE ATOPIC DERMATITIS Biotech Investing
Immix Biopharma Announces Strategic Investment by Houston based Goose Capital, led by founding member Dr. Nancy T. Chang Biotech Investing
Sernova Biotherapeutics to Participate in the H.C. Wainwright 27th Annual Global Investor Conference Biotech Investing
Breakthrough Therapy Designations Surge as $50B Cancer Drug Partnerships Reshape Market Biotech Investing
HOPE Therapeutics, Inc. and NRx Pharmaceuticals, Inc. Complete the Acquisition of Dura Medical; Initial Acquisition in Network of Interventional Psychiatry Clinics Biotech Investing
